ascopubs.org

Infusional CHOP Chemotherapy (CVAD) With or Without Chemosensitizers Offers No Advantage Over Standard CHOP Therapy in the Treatment of Lymphoma: A Southwest Oncology Group Study

Results of Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue in 22 Patients With Refractory or Recurrent Primary CNS Lymphoma or Intraocular Lymphoma PURPOSE: Two phase II studies were ...
ascopubs.org

Hyper-CVAD plus nelarabine in the treatment of newly diagnosed patients with T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma (T-ALL/LL).

Effect of cytogenetics at diagnosis on outcome of CML: Results from the randomized German CML Study IV. This is an ASCO Meeting Abstract from the 2011 ASCO Annual Meeting I. This abstract does not ...
Nature

The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience

Therapeutic options in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma (T-ALL/LL) are limited. 1 We have earlier demonstrated that the hyper-CVAD regimen achieves high rates of ...